FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approves a supplemental application for Octreotide Acetate submitted by Sagent Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Aids-related Diarrhea
• Carcinoid Syndrome
• Esophageal Variceal Bleeding
• Gastroenteropancreatic Neuroendocrine Tumors
• Vipoma

Drugs mentioned

• OCTREOTIDE ACETATE (octreotide acetate)

Snippet

SUPPL AP for OCTREOTIDE ACETATE (OCTREOTIDE ACETATE)